A Woman's World reacts to Roe v. Wade overturned
A Woman's World reacts to Roe v. Wade overturned
Veru Inc. (VERU) delivered earnings and revenue surprises of -55.56% and 42.36%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Pan American Silver (PAAS) delivered earnings and revenue surprises of -121.43% and 16.21%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
The latest analyst coverage could presage a bad day for Novavax, Inc. ( NASDAQ:NVAX ), with the analysts making...
Persistent supply issues have deflated expectations for the Chinese automaker
EV leader Tesla had indicated in January that it would not introduce a new vehicle on the market in 2022.
Let’s talk about electric vehicles (EVs) and their batteries. The high price of gasoline – still up about $2 since President Biden took office – has boosted interest in EVs. Greater customer curiosity will lead naturally to higher demand, and now we get to batteries, and lithium. Lithium is a metallic element essential in the construction of high-voltage battery systems, and every EV built needs an average of 8 kilos of the metal. Industry experts are saying that lithium demand will far outstrip
The last few years saw the markets go crazy. Between the COVID lockdowns and market crash, the rebound recovery, last year’s sustained bull run, and this year’s devastating first half that saw the bull turn into a bear. But in all of that, there have been stocks that have outperformed the market. These winning stocks have attracted attention from Jim Cramer, the well-known host of CNBC’s ‘Mad Money’ program. Among other things, Cramer has been following stocks which won big during the COVID cris
The mercurial stock is down after earnings, but there is still plenty of reason for optimism for long-term investors.
The plant-based meat producer's revenue declined 2% year over year to $147 million, missing analysts' estimates by $2 million. Beyond Meat isn't down for the count, but major setbacks have made it an easy target for the short sellers.
Senseonics (SENS) delivered earnings and revenue surprises of 25% and 12.44%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Among the dozens of stocks to enact splits this year are two industry leaders that scream value and one cash-rich company that's clobbering its shareholders.
Like the telecom industry's other two stalwarts, it wasn't ready for this new competition that didn't exist a few years ago.
Choosing stocks that can weather the storm and do well afterward, too, are the kinds of companies we should seek out, and the following trio of top tech stocks should outperform no matter what the market throws at it. Having shed its Warner Media division into the newly reconstituted Warner Bros Discovery in April, AT&T (NYSE: T) is now able to focus solely on its telecom operations and the rollout of its 5G network that will provide the industry with its next wave of growth. Although AT&T says it's not immune from the recessionary impacts affecting the broader economy, it's capable of managing through them and investing for the long-term benefit of customers and investors.
Smart investors shouldn't be concerned about stock splits. Instead, they should concentrate on a company's fundamentals.
The latest analyst coverage could presage a bad day for Vertex Energy, Inc. ( NASDAQ:VTNR ), with the analysts making...
Long term investing can be life changing when you buy and hold the truly great businesses. And we've seen some truly...
Potential Warner Bros. Discovery, Inc. ( NASDAQ:WBD ) shareholders may wish to note that the Independent Director...
Bausch Health Companies Inc. (NYSE/TSX: BHC), and its gastroenterology business Salix Pharmaceuticals, today announced that, consistent with the company's July 28, 2022, press release, the U.S. District Court of Delaware has issued a decision in the matter of Salix Pharmaceuticals, Ltd. et al v. Norwich Pharmaceuticals, Inc. finding certain XIFAXAN® (rifaximin) 550 mg HE patents valid and infringed and certain XIFAXAN composition and IBS-D patents invalid. As previously stated, the Company will
Satellite pictures released on Thursday showed devastation at a Russian air base in Crimea, hit in an attack that suggested Kyiv may have obtained new long-range strike capability with potential to change the course of the war. Pictures released by independent satellite firm Planet Labs showed three near-identical craters where buildings at Russia's Saki air base had been struck with apparent precision. The base, on the southwest coast of Crimea, had suffered extensive fire damage with the burnt-out husks of at least eight destroyed warplanes clearly visible.
Four years after Siga Technologies (Nasdaq: SIGA) gained approval for a smallpox drug, the Corvallis company is gearing up to get the same antiviral into a clinical trial for monkeypox. Tpoxx, also known as tecovirimat, is the only drug available to treat the virus, though it is not yet approved in the U.S. for the disease. The Food and Drug Administration designated Tpoxx as an investigational drug for monkeypox, allowing it to be released from the Strategic National Stockpile only after prescribers jump through considerable hoops.